Wednesday, 26 August 2026European Markets

SAS AB Stock Bullish Momentum With A 15.45% Rise Before The Weekend

Loading stream...

(VIANEWS) - The Market ended the session with SAS AB (SASNO.OL) jumping 15.45% to kr0.03 on Friday while Oslo Børs Benchmark Index_GI slid 0.41% to kr1,317.77.

SAS AB's last close was kr0.02, 95.18% below its 52-week high of kr0.51.

About SAS AB

SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 134 aircraft, including 16 long-haul aircraft, 87 short-haul aircraft, and 31 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Earnings Per Share

As for profitability, SAS AB has a trailing twelve months EPS of kr-0.7.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SAS AB's EBITDA is 14.18.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 42.04B for the twelve trailing months.

More news about SAS AB (SASNO.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com